These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 34410012)

  • 21. Probiotic Lactobacillus rhamnosus GG Prevents Liver Fibrosis Through Inhibiting Hepatic Bile Acid Synthesis and Enhancing Bile Acid Excretion in Mice.
    Liu Y; Chen K; Li F; Gu Z; Liu Q; He L; Shao T; Song Q; Zhu F; Zhang L; Jiang M; Zhou Y; Barve S; Zhang X; McClain CJ; Feng W
    Hepatology; 2020 Jun; 71(6):2050-2066. PubMed ID: 31571251
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Farnesoid X Receptor: Effective alleviation of rifampicin -induced liver injury.
    Zhou Y; Li M; Cao Y; Chang W; Jia H; Wang L; Xu H; Wang Y; Liu P; Chen WD
    Int Immunopharmacol; 2024 Sep; 139():112799. PubMed ID: 39068755
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Xenobiotic Nuclear Receptor Signaling Determines Molecular Pathogenesis of Progressive Familial Intrahepatic Cholestasis.
    Kim KH; Choi JM; Li F; Arizpe A; Wooton-Kee CR; Anakk S; Jung SY; Finegold MJ; Moore DD
    Endocrinology; 2018 Jun; 159(6):2435-2446. PubMed ID: 29718219
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dehydrodiconiferyl alcohol, a lignan from Herpetospermum pedunculosum, alleviates cholestasis by activating pathways associated with the farnesoid X receptor.
    Wei X; Ma Y; Dong Z; Wang G; Lan X; Liao Z; Chen M
    Phytomedicine; 2021 Jan; 80():153378. PubMed ID: 33113499
    [TBL] [Abstract][Full Text] [Related]  

  • 25. miR-199a-5p inhibits the expression of ABCB11 in obstructive cholestasis.
    Balasubramaniyan N; Devereaux MW; Orlicky DJ; Sokol RJ; Suchy FJ
    J Biol Chem; 2021 Dec; 297(6):101400. PubMed ID: 34774795
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hepatic overexpression of murine Abcb11 increases hepatobiliary lipid secretion and reduces hepatic steatosis.
    Figge A; Lammert F; Paigen B; Henkel A; Matern S; Korstanje R; Shneider BL; Chen F; Stoltenberg E; Spatz K; Hoda F; Cohen DE; Green RM
    J Biol Chem; 2004 Jan; 279(4):2790-9. PubMed ID: 14570929
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hesperidin alleviates cholestasis via activation of the farnesoid X receptor in vitro and in vivo.
    Zhang G; Sun X; Wen Y; Shi A; Zhang J; Wei Y; Wu X
    Eur J Pharmacol; 2020 Oct; 885():173498. PubMed ID: 32841642
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hepatic inflammation caused by dysregulated bile acid synthesis is reversible by butyrate supplementation.
    Sheng L; Jena PK; Hu Y; Liu HX; Nagar N; Kalanetra KM; French SW; French SW; Mills DA; Wan YY
    J Pathol; 2017 Dec; 243(4):431-441. PubMed ID: 28892150
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prevention of spontaneous hepatocarcinogenesis in farnesoid X receptor-null mice by intestinal-specific farnesoid X receptor reactivation.
    Degirolamo C; Modica S; Vacca M; Di Tullio G; Morgano A; D'Orazio A; Kannisto K; Parini P; Moschetta A
    Hepatology; 2015 Jan; 61(1):161-70. PubMed ID: 24954587
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of farnesoid X receptor in determining hepatic ABC transporter expression and liver injury in bile duct-ligated mice.
    Wagner M; Fickert P; Zollner G; Fuchsbichler A; Silbert D; Tsybrovskyy O; Zatloukal K; Guo GL; Schuetz JD; Gonzalez FJ; Marschall HU; Denk H; Trauner M
    Gastroenterology; 2003 Sep; 125(3):825-38. PubMed ID: 12949728
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Paradoxical Effects of Emodin on ANIT-Induced Intrahepatic Cholestasis and Herb-Induced Hepatotoxicity in Mice.
    Wang X; Han L; Bi Y; Li C; Gao X; Fan G; Zhang Y
    Toxicol Sci; 2019 Mar; 168(1):264-278. PubMed ID: 30517764
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Yangonin protects against cholestasis and hepatotoxity via activation of farnesoid X receptor in vivo and in vitro.
    Gao X; Fu T; Wang C; Ning C; Liu K; Liu Z; Sun H; Ma X; Huo X; Yang X; Zou M; Meng Q
    Toxicol Appl Pharmacol; 2018 Jun; 348():105-116. PubMed ID: 29660435
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Farnesoid X Receptor Activation Promotes Hepatic Amino Acid Catabolism and Ammonium Clearance in Mice.
    Massafra V; Milona A; Vos HR; Ramos RJJ; Gerrits J; Willemsen ECL; Ramos Pittol JM; Ijssennagger N; Houweling M; Prinsen HCMT; Verhoeven-Duif NM; Burgering BMT; van Mil SWC
    Gastroenterology; 2017 May; 152(6):1462-1476.e10. PubMed ID: 28130067
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mechanisms of MAFG Dysregulation in Cholestatic Liver Injury and Development of Liver Cancer.
    Liu T; Yang H; Fan W; Tu J; Li TWH; Wang J; Shen H; Yang J; Xiong T; Steggerda J; Liu Z; Noureddin M; Maldonado SS; Annamalai A; Seki E; Mato JM; Lu SC
    Gastroenterology; 2018 Aug; 155(2):557-571.e14. PubMed ID: 29733835
    [TBL] [Abstract][Full Text] [Related]  

  • 35. BRD4 inhibition and FXR activation, individually beneficial in cholestasis, are antagonistic in combination.
    Jung H; Chen J; Hu X; Sun H; Wu SY; Chiang CM; Kemper B; Chen LF; Kemper JK
    JCI Insight; 2020 Dec; 6(1):. PubMed ID: 33290278
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Histone H3K4 trimethylation by MLL3 as part of ASCOM complex is critical for NR activation of bile acid transporter genes and is downregulated in cholestasis.
    Ananthanarayanan M; Li Y; Surapureddi S; Balasubramaniyan N; Ahn J; Goldstein JA; Suchy FJ
    Am J Physiol Gastrointest Liver Physiol; 2011 May; 300(5):G771-81. PubMed ID: 21330447
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Gene expression profiling in human precision cut liver slices in response to the FXR agonist obeticholic acid.
    Ijssennagger N; Janssen AWF; Milona A; Ramos Pittol JM; Hollman DAA; Mokry M; Betzel B; Berends FJ; Janssen IM; van Mil SWC; Kersten S
    J Hepatol; 2016 May; 64(5):1158-1166. PubMed ID: 26812075
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Phosphorylation of hepatic farnesoid X receptor by FGF19 signaling-activated Src maintains cholesterol levels and protects from atherosclerosis.
    Byun S; Jung H; Chen J; Kim YC; Kim DH; Kong B; Guo G; Kemper B; Kemper JK
    J Biol Chem; 2019 May; 294(22):8732-8744. PubMed ID: 30996006
    [TBL] [Abstract][Full Text] [Related]  

  • 39. SIRT1 controls liver regeneration by regulating bile acid metabolism through farnesoid X receptor and mammalian target of rapamycin signaling.
    García-Rodríguez JL; Barbier-Torres L; Fernández-Álvarez S; Gutiérrez-de Juan V; Monte MJ; Halilbasic E; Herranz D; Álvarez L; Aspichueta P; Marín JJ; Trauner M; Mato JM; Serrano M; Beraza N; Martínez-Chantar ML
    Hepatology; 2014 May; 59(5):1972-83. PubMed ID: 24338587
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Editor's Highlight: Clofibrate Decreases Bile Acids in Livers of Male Mice by Increasing Biliary Bile Acid Excretion in a PPARα-Dependent Manner.
    Zhang Y; Lickteig AJ; Csanaky IL; Klaassen CD
    Toxicol Sci; 2017 Dec; 160(2):351-360. PubMed ID: 28973556
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.